ijms-logo

Journal Browser

Journal Browser

Insights on the Role of Stem Cells in Tendon Tissue Engineering: From Basic Science to Translational Medicine

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".

Deadline for manuscript submissions: 15 June 2024 | Viewed by 3242

Special Issue Editors


E-Mail Website
Guest Editor
Department of Medicine, Surgery and Dentistry, University of Salerno, Via S. Allende, 84081 Baronissi, Italy
Interests: human bone marrow mesenchymal stem cells; human Wharton’s Jelly mesenchymal stem cells; tendon stem/progenitor cells; 3D bioengineered scaffolds; tendon regeneration; in vitro models; immunomodulation, tissue engineering; regenerative medicine; drug delivery; bioreactor systems

E-Mail Website
Guest Editor
Laboratory of Translational Medicine, Department of Medicine, Surgery and Dentistry, University of Salerno, Via S. Allende, 84081 Baronissi, Italy
Interests: sports trauma injury, joint replacement, hand & rheumatoid surgery, & adult & paediatric orthopaedics; surgical techniques in the field of knee, foot and ankle, and sports surgery; soft tissues problems
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Tendon injuries remain difficult to manage due to their poor healing ability, ascribable to a low cellularity and hypo-vascularity, leading to scar tissue formation, instead of organized extracellular matrix, thus affecting tendon biomechanical functionality. The currently applied treatments, including exercise, drug delivery, and surgical procedures, are not sufficient for a complete regeneration, which implies the development of promising strategies with the aim to deal with this pathology. To this end, cell-based therapy and tissue engineering represent challenging approaches for the regeneration of damaged tendon tissues with the aim to stimulate self-regeneration or to produce functional implantable tissue replacements. In particular, tissue engineering belongs to a multidisciplinary field that involves the use of a combination of key factors, such as cells, scaffolds, and biochemical and mechanical inputs i) to realize in vitro models and ii) to produce functional tissue-like constructs able to support damaged tissue, inducing its functional recovery. The combinatory effect of two or more factors seems to play a key role in boosting the tendon differentiation of stem cells.

This Special Issue will cover a selection of papers related to the use of stem cells in the development of in vitro 3D bioengineered complex models to understand the specific behavior of tendon healing and regeneration, as well as their translational potential in in vivo models.

Dr. Maria Camilla Ciardulli
Prof. Dr. Nicola Maffulli
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • stem cells
  • tenogenic differentiation
  • 3D in vitro tendon models
  • immunomodulation
  • biomimetic scaffolds
  • in vivo tendon models
  • dynamic cultures

Published Papers (4 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

19 pages, 8830 KiB  
Article
Assessing Bioprinted Functionalized Grafts for Biological Tendon Augmentation In Vitro
by Cristina Del Amo, Miguel Perez-Garrastachu, Ines Jauregui, Xabier Llama-Pino and Isabel Andia
Int. J. Mol. Sci. 2024, 25(9), 4752; https://doi.org/10.3390/ijms25094752 - 26 Apr 2024
Viewed by 262
Abstract
Tendinopathy, characterized by inflammatory and degenerative changes, presents challenges in sports and medicine. In addressing the limitations of conservative management, this study focuses on developing tendon grafts using extrusion bioprinting with platelet-rich plasma (PRP)-infused hydrogels loaded with tendon cells. The objective is to [...] Read more.
Tendinopathy, characterized by inflammatory and degenerative changes, presents challenges in sports and medicine. In addressing the limitations of conservative management, this study focuses on developing tendon grafts using extrusion bioprinting with platelet-rich plasma (PRP)-infused hydrogels loaded with tendon cells. The objective is to understand paracrine interactions initiated by bioprinted tendon grafts in either inflamed or non-inflamed host tissues. PRP was utilized to functionalize methacrylate gelatin (GelMA), incorporating tendon cells for graft bioprinting. Bioinformatic analyses of overexpressed proteins, predictive of functional enrichment, revealed insights into PRP graft behavior in both non-inflamed and inflamed environments. PRP grafts activated inflammatory pathways, including Interleukin 17 (IL-17), neuroinflammation, Interleukin 33 (IL-33), and chemokine signaling. Interleukin 1 beta (IL-1b) in the graft environment triggered p38 mitogen-activated protein kinase (MAPK) signaling, nuclear factor kappa light chain enhancer of activated B cells (NF-kB) canonical pathway, and Vascular Endothelial Growth Factor (VEGF) signaling. Biological enrichment attributed to PRP grafts included cell chemotaxis, collagen turnover, cell migration, and angiogenesis. Acellular PRP grafts differed from nude grafts in promoting vessel length, vessel area, and junction density. Angiogenesis in cellular grafts was enhanced with newly synthesized Interleukin 8 (IL-8) in cooperation with IL-1b. In conclusion, paracrine signaling from PRP grafts, mediated by chemokine activities, influences cell migration, inflammation, and angiogenic status in host tissues. Under inflammatory conditions, newly synthesized IL-8 regulates vascularization in collaboration with PRP. Full article
Show Figures

Graphical abstract

19 pages, 9352 KiB  
Article
ZIM1 Combined with Hydrogel Inhibits Senescence of Primary PαS Cells during In Vitro Expansion
by Yueming Tian, Menglong Hu, Xuenan Liu, Xu Wang, Dazhuang Lu, Zheng Li, Yunsong Liu, Ping Zhang and Yongsheng Zhou
Int. J. Mol. Sci. 2023, 24(11), 9766; https://doi.org/10.3390/ijms24119766 - 05 Jun 2023
Viewed by 1382
Abstract
Bone marrow stem cells (BMSCs) are a promising source of seed cells in bone tissue engineering, which needs a great quantity of cells. Cell senescence occurs as they are passaged, which could affect the therapeutic effects of cells. Therefore, this study aims to [...] Read more.
Bone marrow stem cells (BMSCs) are a promising source of seed cells in bone tissue engineering, which needs a great quantity of cells. Cell senescence occurs as they are passaged, which could affect the therapeutic effects of cells. Therefore, this study aims to explore the transcriptomic differences among the uncultured and passaged cells, finding a practical target gene for anti-aging. We sorted PαS (PDGFR-α+SCA-1+CD45-TER119-) cells as BMSCs by flow cytometry analysis. The changes in cellular senescence phenotype (Counting Kit-8 (CCK-8) assay, reactive oxygen species (ROS) test, senescence-associated β-galactosidase (SA-β-Gal) activity staining, expression of aging-related genes, telomere-related changes and in vivo differentiation potential) and associated transcriptional alterations during three important cell culture processes (in vivo, first adherence in vitro, first passage, and serial passage in vitro) were studied. Overexpression plasmids of potential target genes were made and examed. Gelatin methacryloyl (GelMA) was applied to explore the anti-aging effects combined with the target gene. Aging-related genes and ROS levels increased, telomerase activity and average telomere length decreased, and SA-β-Gal activities increased as cells were passaged. RNA-seq offered that imprinted zinc-finger gene 1 (Zim1) played a critical role in anti-aging during cell culture. Further, Zim1 combined with GelMA reduced the expression of P16/P53 and ROS levels with doubled telomerase activities. Few SA-β-Gal positive cells were found in the above state. These effects are achieved at least by the activation of Wnt/β-catenin signaling through the regulation of Wnt2. The combined application of Zim1 and hydrogel could inhibit the senescence of BMSCs during in vitro expansion, which may benefit clinical application. Full article
Show Figures

Figure 1

Review

Jump to: Research

22 pages, 950 KiB  
Review
Recent Advances in the Use of Stem Cells in Tissue Engineering and Adjunct Therapies for Tendon Reconstruction and Future Perspectives
by Paweł Dec, Małgorzata Żyłka, Piotr Burszewski, Andrzej Modrzejewski and Andrzej Pawlik
Int. J. Mol. Sci. 2024, 25(8), 4498; https://doi.org/10.3390/ijms25084498 - 19 Apr 2024
Viewed by 275
Abstract
Due to their function, tendons are exposed to acute injuries. This type of damage to the musculoskeletal system represents a challenge for clinicians when natural regeneration and treatment methods do not produce the expected results. Currently, treatment is long and associated with long-term [...] Read more.
Due to their function, tendons are exposed to acute injuries. This type of damage to the musculoskeletal system represents a challenge for clinicians when natural regeneration and treatment methods do not produce the expected results. Currently, treatment is long and associated with long-term complications. In this review, we discuss the use of stem cells in the treatment of tendons, including how to induce appropriate cell differentiation based on gene therapy, growth factors, tissue engineering, proteins involved in regenerative process, drugs and three-dimensional (3D) structures. A multidirectional approach as well as the incorporation of novel components of the therapy will improve the techniques used and benefit patients with tendon injuries in the future. Full article
Show Figures

Figure 1

16 pages, 782 KiB  
Review
Cell-Based Therapies for Rotator Cuff Injuries: An Updated Review of the Literature
by Nicholas Hooper, Anuj Marathe, Nitin B. Jain and Prathap Jayaram
Int. J. Mol. Sci. 2024, 25(6), 3139; https://doi.org/10.3390/ijms25063139 - 08 Mar 2024
Viewed by 827
Abstract
This review focuses on non-surgical treatment options for rotator cuff injuries and highlights the potential of mesenchymal stem cells (MSCs) as a potential regenerative approach. MSCs, sourced from various tissues like bone marrow and adipose tissue, exhibit promising mechanisms in vitro, influencing tendon-related [...] Read more.
This review focuses on non-surgical treatment options for rotator cuff injuries and highlights the potential of mesenchymal stem cells (MSCs) as a potential regenerative approach. MSCs, sourced from various tissues like bone marrow and adipose tissue, exhibit promising mechanisms in vitro, influencing tendon-related gene expression and microenvironment modulation. Animal studies support this, showcasing MSCs’ ability to reduce inflammation, improve tissue remodeling, and enhance repaired tendon strength. Human trials, while varied and limited, suggest that MSCs might lower retear rates and enhance post-repair outcomes, but randomized controlled trials yield mixed results, emphasizing the necessity for standardized investigations. Ultimately, while cell-based therapies demonstrate an excellent safety profile, more rigorous clinical trials are necessary to determine their efficacy in improving patient outcomes and achieving lasting structural changes in rotator cuff injuries. Full article
Show Figures

Figure 1

Back to TopTop